Increasing off-label use of antipsychotics for treating anxiety disorders
Low-dose antipsychotics generally safe in patients with intellectual disability, but caution still advised
Warfarin and antidepressants
Clinical guidance for long-term T3 augmentation in major depression
Greater fracture risk with zolpidem than alprazolam or lorazepam in the elderly
Commentary on the Comer et al. study
Slowing AD progression with memantine
Risperidone and decompensation in a previously stable patient
From the FDA